Director at Inspire Medical (NYSE: INSP) sells 696 company shares

Rhea-AI Filing Summary

Inspire Medical Systems director Shawn McCormick reported an open-market sale of 696 shares of Common Stock at $45.31 per share. After this sale, he holds 27,712 shares directly. A separate entry shows an additional 3,000 shares held indirectly by trust, reflecting estate or planning-related ownership.

Insider Trade Summary 10b5-1

Net Seller: 696 shares ($31,536)

Net Sell 2 txns

Insider mcCormick Shawn

Role null

Sold 696 shs ($32K)

Type	Security	Shares	Price	Value
Sale	Common Stock	696	$45.31	$32K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 27,712 shares (Direct, null); Common Stock — 3,000 shares (Indirect, By trust)

Footnotes (1)

Key Figures

Shares sold: 696 shares Sale price per share: $45.31/share Direct holdings after sale: 27,712 shares +1 more

4 metrics

Shares sold 696 shares Open-market sale of Common Stock on 2026-05-08

Sale price per share $45.31/share Price for 696 shares sold on 2026-05-08

Direct holdings after sale 27,712 shares Common Stock directly owned after transaction

Indirect holdings by trust 3,000 shares Common Stock held indirectly by trust as of 2026-05-08

Key Terms

open-market sale, Common Stock, By trust, Form 4

4 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

By trust financial

""nature_of_ownership": "By trust""

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

mcCormick Shawn

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MINNESOTA 55416

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/08/2026		S		696	D	$45.31	27,712	D
Common Stock								3,000	I	By trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

All sale transactions reported herein were made pursuant to a Rule 10b5-1 trading plan dated August 29, 2025.

	/s/ Bryan Phillips, Attorney-in-Fact for Shawn T McCormick	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did INSP director Shawn McCormick report?

Director Shawn McCormick reported an open-market sale of 696 shares of Inspire Medical Systems Common Stock. The transaction was recorded at a price of $45.31 per share and is classified as a non-derivative sale on the Form 4.

How many Inspire Medical Systems (INSP) shares did Shawn McCormick sell?

Shawn McCormick sold 696 shares of Inspire Medical Systems Common Stock. This sale was reported as an open-market transaction, identified with transaction code S, indicating a standard sale of existing shares rather than an option exercise or derivative-related event.

What are Shawn McCormick’s INSP holdings after the reported sale?

Following the sale, Shawn McCormick holds 27,712 shares of Inspire Medical Systems Common Stock directly. The Form 4 also shows an additional 3,000 shares held indirectly by trust, giving a fuller picture of his reported equity exposure to the company.

Was the INSP insider transaction a buy or a sell?

The reported Inspire Medical Systems insider transaction was a sell. Form 4 data classifies it as an open-market sale (transaction code S) of 696 Common Stock shares at $45.31 per share, reducing the reporting person’s directly held share count.

Does Shawn McCormick hold any INSP shares indirectly through a trust?

Yes. In addition to his direct holdings, the filing lists 3,000 Inspire Medical Systems shares held indirectly “By trust.” This indicates a separate ownership structure, such as an estate or family trust, distinct from his 27,712 directly owned shares.